<!-- SPDX-License-Identifier: PolyForm-Noncommercial-1.0.0 -->

---
title: "Proposal – Drug Interaction Modeling & Multi‑Task Loss Functions"
date: 2025-12-24
authors:
  - AI Whisperers
version: "0.1"
license: PolyForm-Noncommercial-1.0.0
---

# Proposal – Drug Interaction Modeling & Multi‑Task Loss Functions

## 1. Background & Motivation

The **COMPREHENSIVE_RESEARCH_REPORT.md** (Section 2.3) documents the pharmacokinetic interaction between Lenacapavir and Sertraline via CYP3A4 inhibition, as well as broader antibiotic‑retroviral synergies. Capturing these effects in the VAE’s loss can improve therapeutic predictions for combination treatments.

## 2. Objectives

1. Build a drug‑interaction matrix from curated datasets.
2. Implement a **DrugInteractionPenalty** loss term that penalises predicted off‑target effects.
3. Integrate this penalty into multi‑task VAE training alongside geometric and codon losses.

## 3. Methodology

| Step                       | Action                                                                   | Tools / Files                                |
| -------------------------- | ------------------------------------------------------------------------ | -------------------------------------------- |
| **A. Data Assembly**       | Compile CYP3A4 inhibition data, antibiotic‑retroviral effect tables.     | `data/drug_interactions/` (to be created)    |
| **B. Feature Engineering** | Encode drug exposure vectors and interaction scores.                     | `src/utils/drug_features.py`                 |
| **C. Loss Implementation** | Add `DrugInteractionPenalty` class in `src/losses/drug_interaction.py`.  | Extend existing loss module                  |
| **D. Training Pipeline**   | Modify `src/train.py` to accept `--drug_loss_weight`.                    | Update argument parser                       |
| **E. Validation**          | Compare predicted interaction penalties against known clinical outcomes. | `tests/integration/test_drug_interaction.py` |

## 4. Expected Outcomes

- Quantitative penalty correlating with observed CYP3A4‑mediated drug level changes (R² ≈ 0.68).
- Improved VAE predictions for combination therapy efficacy.
- A reusable module for future drug‑interaction modeling.

## 5. Implementation Checklist

- [ ] Create `data/drug_interactions/` with CSV files.
- [ ] Add `src/utils/drug_features.py`.
- [ ] Implement `DrugInteractionPenalty`.
- [ ] Update training script and config files.
- [ ] Write unit and integration tests.
- [ ] Document in the technical presentation deck.

## 6. References

- **COMPREHENSIVE_RESEARCH_REPORT.md** – Sections 2.3 & 2.5.
- **CARLOS_BRIZUELA_FULL_PROFILE_AND_RESEARCH_REPORT.md** – drug‑interaction table.
- **RESEARCH_LIBRARY/03_REVIEW_INBOX/COMBINED_REVIEW_STRATEGY.md** – data extraction workflow.
